King’s College

Plasticell, Kings College London to collaborate in blood platelet substitute trials

Thursday, April 20, 2017

Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has partnered with King’s College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells. The work is supported by a MedCity research grant which funds collaboration between leading SMEs and academics from London universities.

[Read More]

BI, EFSD commit $3.3 million to European diabetes research initiatives

Friday, July 19, 2013

The Boehringer Ingelheim (BI) and European Foundation for the Study of Diabetes (EFSD) partnership has announced the recipients of its European-wide funding initiative targeted at diabetes research. Totaling $3.3 million, these are the first grants to be awarded as part of the EFSD/Boehringer Ingelheim European Diabetes Research Programs, which aim to stimulate and accelerate European research in diabetes.

[Read More]

Researchers reveal GR and depression link

Wednesday, April 13, 2011

Scientists in the U.K. using human stem cells say they have discovered how certain antidepressants form new brain cells, according to a Reuters report.  This finding will help researchers develop more effective drugs for treating depression.

[Read More]